Index Rebalance

CSI 300 Index Earning Revision (May): Xinjiang Daqo, TONGWEI, SERES, CHINA VANKE, Wuliangye, CSSC

31 May 2026 By Ke Yan, CFA
← All Research ReportsMore Index Rebalance coverage →

Abstract: We analyzed earnings revisions for CSI 300 component stocks in May 2026. The index rose 1.8% from 4,807 to 4,892, while the 2026E consensus EPS fell 1.5% month on month to 311.4 from 316.0, with 155 stocks revised down versus 80 revised up. Individual stock EPS revisions contributed -4.75 to the index EPS change. The largest negative contributors were CHINA VANKE (-0.49 to index EPS, stock EPS -29.6%), Wuliangye (-0.48, EPS -20.5%), BANK OF BEIJING (-0.33, EPS -10.6%), and SERES (-0.29, EPS -30.7%), while CSSC (+0.34, EPS +19.0%) and ZIJIN MINING (+0.21, EPS +2.3%) were the top positive contributors. Among individual EPS revisions, YONYOU NETWORK TECHNOLOGY led gains at +1,745%, followed by TONGWEI (+458%) and Xinjiang Daqo (+327%), while NEW HOPE LIUHE (-73.9%), MAXSCEND MICROELECTRONICS (-54.6%), and SERES (-30.7%) saw the steepest cuts. On revenue, CAMBRICON (+25.2%) and TONGLING NONFERROUS METALS (+25.1%) led upgrades, while Wuliangye (-19.1%) and JINKO SOLAR (-17.2%) saw the largest revenue estimate reductions.

MAXSCEND MICROELECTRONICS (300782 CH) CHANGCHUN HIGH-TECH INDUSTRY (000661 CH) Xinjiang Daqo (688303 CH) NEW HOPE LIUHE (000876 CH) CHONGQING ZHIFEI BIOLOGICAL PRODUCTS (300122 CH) TONGWEI (600438 CH)

Highlighted Stocks

MAXSCEND MICROELECTRONICS, CHANGCHUN HIGH-TECH INDUSTRY, Xinjiang Daqo, NEW HOPE LIUHE, CHONGQING ZHIFEI BIOLOGICAL PRODUCTS, TONGWEI

Interested in the full report? Get in touch with our team.